Skip Navigation

Watch CNBC's full interview with Sarepta CEO Doug Ingram

In this video

SRPT

Halftime Report

Watch CNBC's full interview with Sarepta CEO Doug Ingram

Doug Ingram, Sarepta Therapeutics CEO and president, sits down with CNBC's Meg Tirrell at the J.P. Morgan health care conference to discuss the company's gene therapy potential.

03:55

Tue, Jan 14 20201:34 PM EST

The Fed won't cut interest rates this year, says Apollo Global's Torsten Slok

The Fed won't cut interest rates this year, says Apollo Global's Torsten Slok

6 hours ago

Tesla's big gamble: Full Self-Driving in the wild

Tesla's big gamble: Full Self-Driving in the wild

May will be a month that determines how returns for the year will look: NYU's Aswath Damodaran

May will be a month that determines how returns for the year will look: NYU's Aswath Damodaran

Black-owned businesses still face headwinds in obtaining capital

Black-owned businesses still face headwinds in obtaining capital

Stocks picks for companies with 'boomerang CEOs'

Stocks picks for companies with 'boomerang CEOs'

The Fed won't cut interest rates this year, says Apollo Global's Torsten Slok

The Fed won't cut interest rates this year, says Apollo Global's Torsten Slok

6 hours ago

Tesla's big gamble: Full Self-Driving in the wild

Tesla's big gamble: Full Self-Driving in the wild

May will be a month that determines how returns for the year will look: NYU's Aswath Damodaran

May will be a month that determines how returns for the year will look: NYU's Aswath Damodaran

Black-owned businesses still face headwinds in obtaining capital

Black-owned businesses still face headwinds in obtaining capital

Stocks picks for companies with 'boomerang CEOs'

Stocks picks for companies with 'boomerang CEOs'